Applied DNA Sciences (APDN) Reports In-Line Q4 EPS, Miss on Revenues
Tweet
Share
E-mailGet Alerts APDN Hot Sheet
Price: $5.62 --0%
Financial Fact:
Research and development: 1.41M
Today's EPS Names:
AFIB, VAXX, NMRD, More
Financial Fact:
Research and development: 1.41M
Today's EPS Names:
AFIB, VAXX, NMRD, More
Join SI Premium – FREE
Applied DNA Sciences (NASDAQ: APDN) reported Q4 EPS of ($0.10), in-line with the analyst estimate of ($0.10). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $1.67 million.
For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolverine World Wide (WWW) Tops Q2 EPS by 2c; offers guidance
- 22nd Century Group (XXII) Misses Q2 EPS by 9800c
- Nauticus Robotics (KITT) Reports Q2 Loss of $2.30
Create E-mail Alert Related Categories
Corporate News, Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
